Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The HDR syndrome is an inherited condition consisting of hypoparathyroidism, sensorineural deafness and renal disease.
Features include always present findings: Basal ganglia calcification, Unilateral renal dysplasia, Aplasia of the uterus, and Aplasia of the vagina and others; and very common findings: Hypoparathyroidism and Inner ear hearing loss (sensorineural hearing impairment). 22 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 10 | Nephrocalcinosis, Renal dysplasia, Unilateral renal dysplasia |
Eyes | 2 | Ptosis, Horizontal nystagmus |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Hormones | 1 | Primary amenorrhea |
GATA3 encodes GATA binding protein 3 (443 aa). Transcriptional activator which binds to the enhancer of the T-cell receptor alpha and delta genes. Binds to the consensus sequence 5'-AGATAG-3'. Highest expression in Skin Not Sun Exposed Suprapubic (269.4 TPM) and Skin Sun Exposed Lower leg (244.1 TPM).
Hypoparathyroidism-deafness-renal disease syndrome is caused by mutations in the GATA3 gene on chromosome 10.
The GATA3 protein participates in Expression of GATA3, Expression of GATA3 in the nephric duct, and GATA3 regulates expression of IL5 pathways.
GATA3 is classified as a druggable target (Clinically Actionable and Transcription Factor categories) with score 1.4.
Genetic testing for GATA3 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 9 always present features, 2 very common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hypoparathyroidism-deafness-renal disease syndrome.
22 publications have been identified in PubMed for hypoparathyroidism-deafness-renal disease syndrome. Research spans Case Report / Case Series (77%), Review / Meta-Analysis (14%), and Other (5%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 17 | 77% |
Research summaries | 3 | 14% |
Other research | 1 | 5% |
Laboratory research | 1 | 5% |
Bibik E (2026). [PMID: 41952051](https://pubmed.ncbi.nlm.nih.gov/41952051/). *Clin Endocrinol (Oxf)*. [Case Report / Case Series]
Meiss LN (2026). [PMID: 41190486](https://pubmed.ncbi.nlm.nih.gov/41190486/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Zuo B (2026). [PMID: 41673963](https://pubmed.ncbi.nlm.nih.gov/41673963/). *Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery*. [Case Report / Case Series]
Torchinsky MY (2026). [PMID: 41756473](https://pubmed.ncbi.nlm.nih.gov/41756473/). *JCEM case reports*. [Case Report / Case Series]
Çordan İ (2026). [PMID: 42017099](https://pubmed.ncbi.nlm.nih.gov/42017099/). *Cureus*. [Case Report / Case Series]
Alvey L (2025). [PMID: 41064049](https://pubmed.ncbi.nlm.nih.gov/41064049/). *Molecular syndromology*. [Case Report / Case Series]
Domínguez-Ruiz M (2025). [PMID: 40650141](https://pubmed.ncbi.nlm.nih.gov/40650141/). *International journal of molecular sciences*. [Case Report / Case Series]
Valenciaga A (2025). [PMID: 39822657](https://pubmed.ncbi.nlm.nih.gov/39822657/). *JCEM case reports*. [Case Report / Case Series]
Roztoczyńska D (2025). [PMID: 40686918](https://pubmed.ncbi.nlm.nih.gov/40686918/). *Case reports in pediatrics*. [Other]
Satariano M (2025). [PMID: 41019281](https://pubmed.ncbi.nlm.nih.gov/41019281/). *Case reports in nephrology*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 10:51 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning hypoparathyroidism-deafness-renal disease syndrome
Updated Jul 8, 2026
A recent study explores the relationship between central sleep apnea and renal and endocrine diseases, highlighting potential implications for patient management. This research adds to the understanding of how these conditions may interact.